Trial · NCT07887269
NUS Health Study: Improving Sleep, Sedentariness and Physical Activity in NUS Staff
NCT07887269, Not applicable, Recruiting, National University of Singapore
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. NUS Health Study: Improving Sleep, Sedentariness and Physical Activity in NUS Staff. Trials, record NCT07887269. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07887269
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- NUS Health Study: Improving Sleep, Sedentariness and Physical Activity in NUS Staff
- NCT number
- NCT07887269
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 2,000 participants, estimated
- Lead sponsor
- National University of Singapore
- Conditions
- Focused Strategies to Optimize Sleep, Reduce Sedentary Behaviour, and Enhance Incidental Physical Activity
- Interventions
- NUS Health Prog
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Sendentariness, via OURA ring | Through study completion, daily, an average of 2 years | Amount of sedentary time daily, as measured by the OURA ring's sedentariness metric (energy expenditure of 1.5 metabolic equivalents (METs) or less ). |
| Primary | Moderate-to-vigorous activity (MVPA), via OURA ring | Through study completion, daily, an average of 2 years | Amount of daily moderate-to-vigorous activity (MVPA), as measured by the OURA ring. |
| Primary | Light-intensity physical activity (LPA), via OURA ring | Through study completion, daily, an average of 2 years | Amount of daily light-intensity physical activity (LPA), as measured by the OURA ring. |
| Primary | Sleep duration, via OURA ring | Through study completion, daily, an average of 2 years | Sleep duration as measured by the OURA ring. |
| Primary | Sleep duration variability | Through study completion, an average of 2 years | The dispersion of daily sleep duration values around a participant's personal average. |
| Primary | Sleep onset time, via OURA ring | Through study completion, daily, an average of 2 years | Sleep onset time as measured by the OURA ring. |
| Primary | Sleep onset variability | Through study completion, an average of 2 years | The dispersion of daily sleep onset timing values around a participant's personal average. |
| Primary | Glucose trends across 2 weeks | 2 weeks measurement period at baseline; subsequently at 9 months, and 15 months after baseline measurement | Measured via Continuous Glucose Monitor |
| Primary | Full blood count | At baseline; subsequently 9 months, and 15 months after baseline measurement | Measured via venous blood collection |
| Primary | Liver panel | At baseline; subsequently at 9 months, and 15 months after baseline measurement | Measured via venous blood collection |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 33109190 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07887269
GET https://conductscience.org/api/trials/v1/NCT07887269/registered